Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

Share Price is delayed by 15 minutes
Get Live Data
331.50    0.00 (0.00%)
Bid:
330.00
Ask:
333.00
Spread: 3.00 (0.909%)
Market Cap: £228.89m
ANCR Live PriceLast checked at - London Stock Exchange

Intraday Animalcare Grp Share Chart

Disposal

20 Sep 2010 07:00

RNS Number : 9291S
Animalcare Group PLC
20 September 2010
Β 

ο»Ώ

Β 

Animalcare Group plc

Β 

Disposal of the Agricultural businesses for Β£3.25m cash

Focus on core veterinary medicines business

Β 

Animalcare Group plc ("the Group" or "Animalcare"), a leading supplier of veterinary medicines and other products to the veterinary and agricultural markets, is pleased to announce that it has completed the sale of the entire issued share capital of Fearing International (Stock Aids) Limited ("Fearing") and the business and assets of Ritchey Limited (together "the Agricultural businesses") for an aggregate cash consideration of approximately Β£3.25 million ("the Disposal") to Tru-Test UK Limited a wholly owned subsidiary of Tru-Test Limited a New Zealand based agricultural technology company. The sale includes the sale of all assets of the businesses including the working capital. The final amount to be received is subject to the preparation of completion accounts to settlement date.

Β 

In the 'Pre-close Trading Update' released on 13 July 2010, the Group announced it was reviewing the strategic direction of the Agricultural businesses. Following this review, the Board believes the Disposal will allow the Group to focus all its attention on its core Animalcare veterinary medicines business.

Β 

The Agricultural businesses focus on the supply of livestock identification and welfare products to agricultural retailers and farmers in the United Kingdom and the Republic of Ireland.

Β 

At 30 June 2009, the Agricultural businesses comprised net assets of Β£4.83 million including fixed assets of Β£1.08 million and stock of Β£0.85 million. In the 12 months to 30 June 2009, the Agricultural businesses contributed approximately Β£0.57 million of operating profit before impairment of goodwill and tax on revenues of Β£7.12 million. The service contracts of all employees of the current Agricultural businesses will transfer on completion of the Disposal.Β 

Β 

Following completion of the Disposal, the Group intends to consider over the next few weeks the most appropriate use of the proceeds of this sale.

Β 

The Group is also finalising the strategic review of its loss making Travik Chemicals business and expects to make another announcement in due course.

Β 

James Lambert, Chairman of Animalcare Group plc, commented: "With approximately 80% of Group profits being generated from the Animalcare veterinary medicines and supplies business the Board has decided on focusing all its resources on optimising the growth of the veterinary business."

Β 

For further information, please contact:

Β 

Animalcare Group plc

Stephen Wildridge (Chief Executive)

01904 487 601

Brewin Dolphin (NOMAD)

Neil Baldwin

0845 213 4726

Walbrook PR Ltd

020 7933 8787

Paul McManus

07980 541 893

paul.mcmanus@walbrookpr.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DISGGUWGBUPUUMR
Date   Source Headline
8th Jul 20211:00 pmRNSProposed Secondary Placing
1st Jul 20217:00 amRNSTotal Voting Rights
21st Jun 20217:00 amRNSExercise of options
17th Jun 202110:17 amRNSDirector/PDMR Notification
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20215:03 pmRNSResult of 2021 AGM
17th May 20217:00 amRNSAnnual Report 2020 and Notice of AGM
22nd Apr 20217:00 amRNSDaxocox approved by EU and UK authorities
30th Mar 20217:00 amRNSFull Year Results 2020
23rd Mar 20217:00 amRNSNotification of major holding
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20213:43 pmRNSDaxocox receives positive opinion from CVMP in EU
8th Feb 20212:46 pmRNSNotification of major holding
1st Feb 20217:00 amRNSAppointment of Nominated Advisor and Joint Broker
21st Jan 20217:00 amRNSTrading Update and Notice of Full Year Results
18th Nov 20207:00 amRNSGrant of options
29th Sep 20207:00 amRNSInterim Results H1 2020
28th Sep 20207:00 amRNSAnimalcare and Kane Biotech to target biofilms
23rd Jul 20207:00 amRNSTrading Update and Notice of Results
30th Jun 20204:00 pmRNSResult of AGM 2020
9th Jun 20203:55 pmRNS2019 Annual Report and Notice of 2020 AGM
28th May 20207:00 amRNSFull year results 2019
18th May 202011:20 amRNSNotice of Full Year 2019 Results
25th Mar 20207:00 amRNSTrading update, revised date for full year results
23rd Jan 20207:00 amRNSTrading Update & Notice of Results
17th Jan 20208:55 amRNSHoldings in Company
24th Sep 20197:00 amRNSHalf Year Results
25th Jul 20197:00 amRNSDirectorate Change
23rd Jul 20197:00 amRNSTrading Update & Notice of Results
16th Jul 201911:37 amRNSNotification of major holdings
25th Jun 20191:40 pmRNSResult of AGM
19th Jun 20193:52 pmRNSBoard change
10th Jun 20192:55 pmRNSDirector/PDMR Shareholding
22nd May 20197:00 amRNSAnnual Report and Notice of Annual General Meeting
8th May 201910:35 amRNSDividend Declaration
30th Apr 20197:00 amRNS2018 Full Year Results
21st Jan 20197:00 amRNSTrading Update and Notice of Results
30th Oct 20187:50 amRNSAdditional Listing
1st Oct 201812:45 pmRNSAdditional Listing
25th Sep 20185:36 pmRNSDividend Declaration
25th Sep 20187:00 amRNSHalf Year Results
4th Sep 20187:41 amRNSAnimalcare announces sale of Wholesale Division
29th Aug 20185:16 pmRNSHolding(s) in Company
3rd Aug 20187:01 amRNSTrading update & Notice of Results
3rd Aug 20187:00 amRNSAnimalcare announces leadership change
9th Jul 20187:00 amRNSCortacare receives positive opinion from CVMP
27th Jun 20182:18 pmRNSResult of AGM
15th Jun 201811:05 amRNSAdditional Listing
30th May 20181:17 pmRNSAnnual Financial Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.